TAKEDA PHARMA (TKD HM) stock market data APIs
€25.774
-0.1(-0.4%)
as of September 15, 2025
Try our APIs with
free plan!
TAKEDA PHARMA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for TKD.HM.
Prev. Close
25.774
Open
25.6735
High
25.6735
Low
25.774
52 wk Range
24.0125-27.7195
Market Cap
37 823 M
Dividends (Yield)
3.2068
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get TAKEDA PHARMA data using free add-ons & libraries
Get TAKEDA PHARMA Fundamental Data
TAKEDA PHARMA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TAKEDA PHARMA News
New
Takeda Pharmaceutical (TSE:4502) Prepares For Leadership Transition With New Executives
Takeda Pharmaceutical recently announced significant leadership changes, with Rhonda Pacheco joining as President of the U.S. Business Unit and Julie Kim preparing for a CEO transition. These moves al...
Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit
Rhonda Pacheco to become president of Takeda's U.S. Business Unit − Rhonda Pacheco to Succeed Julie Kim, Who Was Appointed to Be Takeda’s Next CEO CAMBRIDGE, Mass., September 11, 2025--(BUSINESS...
Assessing Takeda Stock After Recent 6% Jump and New FDA Approval for HyQvia Expansion
Thinking about what to do with Takeda Pharmaceutical stock? You're definitely not alone. Whether you already hold shares, are considering jumping in, or simply like to keep tabs on the world’s large...
Takeda (TSE:4502) Valuation in Focus After Narcolepsy Trial Success and VONVENDI FDA Expansion
If you’ve been following Takeda Pharmaceutical (TSE:4502), you probably noticed the uptick in market chatter this week. The company just announced impressive Phase 3 clinical trial results for its i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
